Niquitin Minilozenge Citrus (Nicotine)

Nicotine, the active ingredient in Niquitin Minilozenge Citrus, is a nicotine replacement therapy presented as a lozenge for oromucosal use. It helps adults who wish to quit smoking by reducing withdrawal symptoms and cravings.

GNH USA supplies Niquitin Minilozenge Citrus as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Niquitin Minilozenge Citrus, a nicotine replacement therapy, is used to support smoking cessation by addressing nicotine dependence. - Smoking cessation: assists adult smokers in quitting by alleviating nicotine withdrawal symptoms. - Reduction of nicotine cravings: provides controlled nicotine delivery to lessen the urge to smoke. - Adjunct to behavioral counseling: used together with counseling programs to improve quit rates.

Niquitin Minilozenge Citrus may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: feeling of queasiness after lozenge use. - Hiccups: brief episodes of involuntary diaphragm contraction. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention. - Chest pain or palpitations: may indicate cardiovascular stress and should be evaluated promptly. - Persistent dizziness: prolonged vertigo that does not resolve.

When using Niquitin Minilozenge Citrus, certain precautions should be observed to ensure safe and effective use. - Assess nicotine dependence: determine appropriate lozenge strength and duration with a healthcare professional. - Avoid use in non‑smokers: nicotine replacement is intended for individuals actively trying to quit smoking. - Monitor cardiovascular status: patients with heart disease should use under medical supervision. - Limit concurrent nicotine sources: do not combine with other nicotine products to prevent excess exposure. - Pregnancy and lactation: discuss risks with a clinician as safety data are limited. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nicotine may interact with certain medicines, altering their effects or increasing adverse reactions.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use can heighten hypertensive risk. - Insulin or oral hypoglycemics: nicotine may affect blood glucose control, requiring dose adjustment. - Warfarin: nicotine may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: nicotine can reduce their efficacy in controlling heart rate. - Theophylline: nicotine may increase plasma concentrations, necessitating monitoring. - Antidepressants (SSRIs): nicotine may alter metabolism, requiring observation for side effects.